CN103341069B - 一种治疗冠心病心绞痛的藏药及其制备方法 - Google Patents
一种治疗冠心病心绞痛的藏药及其制备方法 Download PDFInfo
- Publication number
- CN103341069B CN103341069B CN201310297875.8A CN201310297875A CN103341069B CN 103341069 B CN103341069 B CN 103341069B CN 201310297875 A CN201310297875 A CN 201310297875A CN 103341069 B CN103341069 B CN 103341069B
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- preparation
- active component
- angina pectoris
- tibetan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 206010002383 Angina Pectoris Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 13
- 240000001312 Pecteilis susannae Species 0.000 claims description 12
- 235000012239 silicon dioxide Nutrition 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 238000007560 sedimentation technique Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 208000002193 Pain Diseases 0.000 abstract description 5
- 230000036407 pain Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 240000001723 Entada phaseoloides Species 0.000 abstract description 2
- 241000382298 Lagotis Species 0.000 abstract description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 2
- 240000000513 Santalum album Species 0.000 abstract description 2
- 235000008632 Santalum album Nutrition 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- 238000011282 treatment Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 11
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 108010088842 Fibrinolysin Proteins 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 6
- 229940012957 plasmin Drugs 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000000302 ischemic effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 229960003699 evans blue Drugs 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 230000003533 narcotic effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 208000008286 Aortic Arch Syndromes Diseases 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241001317465 Bambusa textilis Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 241000501717 Gentiana urnula Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000382297 Lagotis brachystachya Species 0.000 description 1
- 241000600550 Lagotis brevituba Species 0.000 description 1
- 241000172304 Lepus oiostolus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000221035 Santalaceae Species 0.000 description 1
- 241000403513 Schizostachyum chinense Species 0.000 description 1
- 244000218979 Spondias axillaris Species 0.000 description 1
- 235000014116 Spondias axillaris Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000001106 Takayasu Arteritis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 208000026915 cervical aortic arch Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000095 emetic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310297875.8A CN103341069B (zh) | 2013-07-16 | 2013-07-16 | 一种治疗冠心病心绞痛的藏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310297875.8A CN103341069B (zh) | 2013-07-16 | 2013-07-16 | 一种治疗冠心病心绞痛的藏药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103341069A CN103341069A (zh) | 2013-10-09 |
CN103341069B true CN103341069B (zh) | 2014-11-12 |
Family
ID=49275929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310297875.8A Active CN103341069B (zh) | 2013-07-16 | 2013-07-16 | 一种治疗冠心病心绞痛的藏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103341069B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398809A (zh) * | 2014-11-09 | 2015-03-11 | 朱海燕 | 一种用于治疗冠心病的中药组合物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169299A (zh) * | 1996-07-02 | 1998-01-07 | 白涛 | 麝香保宁丸 |
-
2013
- 2013-07-16 CN CN201310297875.8A patent/CN103341069B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169299A (zh) * | 1996-07-02 | 1998-01-07 | 白涛 | 麝香保宁丸 |
Non-Patent Citations (5)
Title |
---|
《八味清心沉香胶囊与散剂对动物心血管与镇静作用的对比研究》;毕力格;《中国民族医药杂志》;20070331(第3期);64-65 * |
《蒙医药治疗心刺痛的临床体会》;敖特根;《中国民族民间医药》;20111231(第16期);3-4 * |
中华人民共和国卫生部.乌努龙胆、兔心、兔耳草、榼藤子.《中华人民共和国卫生部药品标准.藏药(第一册)》.1995,17、62-63、118. * |
敖特根.《蒙医药治疗心刺痛的临床体会》.《中国民族民间医药》.2011,(第16期),3-4. * |
毕力格.《八味清心沉香胶囊与散剂对动物心血管与镇静作用的对比研究》.《中国民族医药杂志》.2007,(第3期),64-65. * |
Also Published As
Publication number | Publication date |
---|---|
CN103341069A (zh) | 2013-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101002912B (zh) | 用于治疗痛经的月舒滴丸制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103749819B (zh) | 一种降糖降脂的山茱萸保健茶及其制备方法 | |
CN108159213A (zh) | 一种用于治疗冠心病的中药组合物及其制备方法 | |
CN101879272B (zh) | 一种治疗冠心病的中药复方及其制备方法与应用 | |
CN103341069B (zh) | 一种治疗冠心病心绞痛的藏药及其制备方法 | |
CN102526631B (zh) | 治疗扩张型心肌病的中药制剂、片剂、胶囊剂及制备方法 | |
CN104324261A (zh) | 治疗高血糖的药物组合物及其制备方法 | |
CN101897933A (zh) | 一种治疗白癜风的中成药 | |
CN105055967B (zh) | 一种具有辅助降血糖功能的复方保健品及制备方法 | |
CN106109951A (zh) | 防治高血糖、高血脂、高血压的药物及其制备方法 | |
CN102784240B (zh) | 一种治疗冠心病心绞痛藏药的制备方法 | |
CN102698185B (zh) | 一种治疗高血脂症的藏药及其制备方法 | |
CN101947299B (zh) | 一种治疗冠心病的药物组合物 | |
CN105902897A (zh) | 一种治疗胰腺癌的药物制剂及其用途 | |
CN101632783B (zh) | 一种中药组合物在制备治疗肺原性心脏病药物中的应用 | |
CN104689241A (zh) | 一种治疗气滞血瘀型冠心病的药物及其制备方法 | |
CN104825922A (zh) | 具有抗结直肠癌活性的中药组合物及其制备方法和应用 | |
CN102793801B (zh) | 一种治疗冠心病心绞痛的藏药 | |
CN104721595B (zh) | 一种治疗高脂血症的中药组合物 | |
CN106728828A (zh) | 一种治疗冠心病的中药制剂及其制备工艺 | |
CN103948767A (zh) | 一种治疗心脑血管疾病的药物组合物及其制备方法和用途 | |
CN108743885A (zh) | 一种治疗糖尿病大血管病变的中药及其制备方法 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN102973726A (zh) | 一种用于高血压的中成药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190225 Address after: 810003 No. 18 Jingsan Road, Qinghai Biotechnology Industrial Park, Xining City, Qinghai Province Patentee after: Jiumei Pengcuo Address before: 810008 Room 341, Building 20, Xishan 1st Lane, Chengxi District, Xining City, Qinghai Province Patentee before: Song Yongxin |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tibetan medicament for treating angina pectoris and preparation method thereof Effective date of registration: 20200525 Granted publication date: 20141112 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2020630000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210517 Granted publication date: 20141112 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2020630000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Tibetan medicine for treating angina pectoris of coronary heart disease and its preparation method Effective date of registration: 20210602 Granted publication date: 20141112 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2021630000003 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230608 Granted publication date: 20141112 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo|Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230815 Address after: Room 1231, Building 11, No. 90 Wusi West Road, Chengxi District, Xining City, Qinghai Province, 810000 Patentee after: Yang Cuoji Address before: 810003 18, No. three, Qinghai biological science and Technology Industrial Park, Qinghai, Xining Patentee before: Jiumei Pengcuo |
|
TR01 | Transfer of patent right |